The Life Sciences industry has stayed flat over the last week. The past year has been better, since the industry has gained 8.0% in that time. As for the next few years, earnings are expected to grow by 17% per annum.
Has the U.S. Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 23 May 2024 | US$736.1b | US$141.5b | US$12.4b | 38.4x | 59.2x | 5.2x |
Sat, 20 Apr 2024 | US$682.0b | US$142.0b | US$12.8b | 41x | 53.3x | 4.8x |
Mon, 18 Mar 2024 | US$741.1b | US$142.1b | US$12.8b | 43.9x | 57.7x | 5.2x |
Wed, 14 Feb 2024 | US$697.5b | US$142.2b | US$12.8b | 40.3x | 54.3x | 4.9x |
Fri, 12 Jan 2024 | US$692.4b | US$153.9b | US$14.2b | 35.5x | 48.9x | 4.5x |
Sun, 10 Dec 2023 | US$644.8b | US$153.7b | US$14.0b | 35.2x | 46x | 4.2x |
Tue, 07 Nov 2023 | US$595.2b | US$153.9b | US$11.0b | 30.3x | 54x | 3.9x |
Thu, 05 Oct 2023 | US$640.4b | US$154.6b | US$11.2b | 32.8x | 57.2x | 4.1x |
Sat, 02 Sep 2023 | US$735.8b | US$154.6b | US$11.2b | 33.1x | 65.7x | 4.8x |
Mon, 31 Jul 2023 | US$739.7b | US$154.7b | US$11.6b | 31.5x | 63.6x | 4.8x |
Wed, 28 Jun 2023 | US$677.2b | US$152.4b | US$12.5b | 29.3x | 54.2x | 4.4x |
Fri, 26 May 2023 | US$671.4b | US$152.2b | US$12.5b | 27.8x | 53.7x | 4.4x |
Sun, 23 Apr 2023 | US$728.5b | US$154.6b | US$10.8b | 29.9x | 67.4x | 4.7x |
Tue, 21 Mar 2023 | US$700.7b | US$154.5b | US$10.8b | 26.2x | 64.8x | 4.5x |
Thu, 16 Feb 2023 | US$749.3b | US$154.2b | US$8.6b | 32.1x | 87x | 4.9x |
Sat, 14 Jan 2023 | US$761.4b | US$155.3b | US$8.5b | 30.6x | 89.3x | 4.9x |
Mon, 12 Dec 2022 | US$761.9b | US$155.1b | US$8.8b | 28.4x | 86.8x | 4.9x |
Wed, 09 Nov 2022 | US$707.8b | US$154.9b | US$9.1b | 26.4x | 78.1x | 4.6x |
Fri, 07 Oct 2022 | US$749.3b | US$152.5b | US$17.0b | 24.9x | 44.1x | 4.9x |
Sun, 04 Sep 2022 | US$753.3b | US$152.3b | US$17.3b | 28.7x | 43.5x | 4.9x |
Tue, 02 Aug 2022 | US$829.5b | US$151.6b | US$18.2b | 33.7x | 45.5x | 5.5x |
Thu, 30 Jun 2022 | US$718.3b | US$148.1b | US$20.1b | 30.5x | 35.7x | 4.9x |
Sat, 28 May 2022 | US$773.5b | US$148.1b | US$20.1b | 31.8x | 38.5x | 5.2x |
Mon, 25 Apr 2022 | US$806.5b | US$147.3b | US$25.4b | 33.7x | 31.8x | 5.5x |
Wed, 23 Mar 2022 | US$873.3b | US$145.0b | US$25.3b | 36.9x | 34.5x | 6x |
Fri, 18 Feb 2022 | US$832.6b | US$144.4b | US$25.3b | 37.6x | 32.9x | 5.8x |
Sun, 16 Jan 2022 | US$878.1b | US$138.0b | US$27.3b | 39.9x | 32.1x | 6.4x |
Tue, 14 Dec 2021 | US$963.9b | US$138.0b | US$27.3b | 43.1x | 35.3x | 7x |
Thu, 11 Nov 2021 | US$952.9b | US$137.6b | US$27.1b | 45.8x | 35.1x | 6.9x |
Sat, 09 Oct 2021 | US$709.0b | US$105.9b | US$18.6b | 46x | 38.2x | 6.7x |
Mon, 06 Sep 2021 | US$755.0b | US$106.0b | US$18.6b | 51.1x | 40.6x | 7.1x |
Wed, 04 Aug 2021 | US$714.4b | US$105.8b | US$18.7b | 47.1x | 38.3x | 6.8x |
34.4x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | -0.19% | |
Healthcare | -0.012% | |
Life Sciences | -1.26% | |
Clinical Research and Equipment | -1.26% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
DHR Danaher | US$267.19 | 1.4% +US$2.8b | 17.3% | PE48.6x | |
RVTY Revvity | US$112.67 | 5.0% +US$661.4m | -3.8% | PE75.8x | |
BRKR Bruker | US$78.29 | 1.0% +US$113.4m | 10.3% | PE28.3x | |
ABCL AbCellera Biologics | US$3.86 | 4.3% +US$47.0m | -45.0% | PS31.7x | |
SYNH Syneos Health | US$42.98 | 0.6% +US$24.9m | -8.8% | PE62.6x |